苑东生物: 苑东生物：独立董事提名人声明与承诺

Core Viewpoint - The nomination of Li Weifeng as an independent director candidate for Chengdu Yuandong Pharmaceutical Co., Ltd. has been made by the controlling shareholder Wang Ying, who asserts that the candidate meets all necessary qualifications and independence criteria [1][5]. Summary by Relevant Sections Nomination and Qualifications - Wang Ying, the controlling shareholder, has nominated Li Weifeng as an independent director candidate for the fourth board of Chengdu Yuandong Pharmaceutical Co., Ltd. The nominee has agreed to the position and possesses the required professional knowledge and experience [1]. - The nominee has over 5 years of relevant work experience in law, economics, accounting, finance, or management, and has completed the necessary training for independent directors [1]. Compliance with Regulations - The nominee's qualifications comply with various legal and regulatory requirements, including the Company Law of the People's Republic of China and the regulations set forth by the China Securities Regulatory Commission [1]. - Specific regulations regarding the independence of directors have been adhered to, ensuring that the nominee does not fall under any disqualifying conditions [2][3]. Independence Criteria - The nominee is confirmed to be independent, not holding any significant shares or positions that could compromise their impartiality [2][3]. - The nominee has no adverse records, such as administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [4]. Additional Information - The nominee has not served as an independent director in more than three domestic listed companies and has not held the position in Chengdu Yuandong Pharmaceutical Co., Ltd. for more than six years [4]. - The nomination has passed the qualification review by the board's nomination committee, confirming no conflicts of interest exist between the nominator and the nominee [4].